CONTEXT Therapeutics is empowering people to take back their lives by advancing novel medicines for hormone driven cancers

Our Focus

Hormone receptor positive (HR+) cancers, including, prostate, breast, and ovarian result in >100,000 deaths per year in the United States. Decades old antihormonals and chemotherapies are still the most used therapies to treat these cancers.

Lead Program

Apristor is an investigational medicine for breast, ovarian, and endometrial cancers. These cancers are progesterone-dependent and Apristor functions by blocking the progesterone receptor.

Sharing our Values

We are united by our passion for helping people with cancer. They deserve better. Their families deserve better. It is our job is to help them.

We believe it is possible. We will find a way.

latest news

Cancer Progress
May 7-8
New York, NY

American Society of Clinical Oncology (ASCO)
May 31-June 4
Chicago, IL